|
POMT2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.72719999996995E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.751800E-04 |
| Normal-vs-Stage2 |
5.459600E-02 |
| Normal-vs-Stage3 |
3.612200E-01 |
| Normal-vs-Stage4 |
8.152400E-01 |
| Stage1-vs-Stage2 |
8.433000E-01 |
| Stage1-vs-Stage3 |
2.581200E-01 |
| Stage1-vs-Stage4 |
1.361760E-01 |
| Stage2-vs-Stage3 |
3.297400E-01 |
| Stage2-vs-Stage4 |
1.354180E-01 |
| Stage3-vs-Stage4 |
4.776800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.58929999999535E-06 |
| Normal-vs-AfricanAmerican |
1.159950E-02 |
| Normal-vs-Asian |
1.680960E-01 |
| Caucasian-vs-AfricanAmerican |
2.696400E-01 |
| Caucasian-vs-Asian |
1.738860E-03 |
| AfricanAmerican-vs-Asian |
6.677600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.30450000000038E-05 |
| Normal-vs-Female |
4.383900E-04 |
| Male-vs-Female |
1.722960E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.891900E-02 |
| Normal-vs-Extreme_Weight |
2.374000E-02 |
| Normal-vs-Obese |
2.057700E-03 |
| Normal-vs-Extreme_Obese |
8.570500E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.551600E-01 |
| Normal_Weight-vs-Obese |
3.905800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.822800E-01 |
| Extreme_Weight-vs-Obese |
2.111200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.740600E-01 |
| Obese-vs-Extreme_Obese |
8.698800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.246800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.67179999999156E-06 |
| Normal-vs-Age(61-80Yrs) |
1.282900E-03 |
| Normal-vs-Age(81-100Yrs) |
5.525600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.634800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.670000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.153400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.619900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.363360E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.142800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.42489994750628E-09 |
| Normal-VS-Type2 PRCC |
5.521200E-01 |
| Normal-VS-KIRP CIMP |
2.324000E-02 |
| Normal-VS-Unclassified PRCC |
5.555500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.2313000000016E-05 |
| Type1 PRCC-VS-KIRP CIMP |
7.56390000000717E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
6.848000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.770300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.807940E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.418800E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.228430E-01 |
| Normal-vs-N1 |
7.592600E-01 |
| Normal-vs-N2 |
3.596200E-01 |
| N0-vs-N1 |
4.810000E-01 |
| N0-vs-N2 |
2.874000E-01 |
| N1-vs-N2 |
5.678400E-01 |
|
|
